MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 297 filers reported holding MEDIVATION INC in Q3 2014. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $215,865,000 | +32.5% | 3,579,877 | +1.0% | 0.18% | +29.8% |
| Q1 2016 | $162,950,000 | +11.5% | 3,543,891 | +17.2% | 0.14% | +12.8% |
| Q4 2015 | $146,195,000 | -52.0% | 3,024,324 | -57.8% | 0.12% | -8.8% |
| Q3 2015 | $304,746,000 | +47.4% | 7,170,514 | +296.0% | 0.14% | -19.4% |
| Q2 2015 | $206,807,000 | -5.4% | 1,810,915 | +6.9% | 0.17% | -5.6% |
| Q1 2015 | $218,626,000 | -1.6% | 1,693,858 | -24.1% | 0.18% | -5.3% |
| Q4 2014 | $222,158,000 | -39.6% | 2,230,276 | -40.1% | 0.19% | -43.5% |
| Q3 2014 | $368,081,000 | +6.2% | 3,722,893 | -17.2% | 0.34% | +5.7% |
| Q2 2014 | $346,616,000 | +21.3% | 4,497,073 | +1.3% | 0.32% | +19.5% |
| Q1 2014 | $285,734,000 | -13.5% | 4,438,957 | -14.2% | 0.27% | -14.5% |
| Q4 2013 | $330,296,000 | +6.0% | 5,175,283 | -0.4% | 0.31% | +0.6% |
| Q3 2013 | $311,490,000 | +17.7% | 5,196,508 | -3.4% | 0.31% | +12.0% |
| Q2 2013 | $264,658,000 | – | 5,379,111 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,244,519 | $221,584,000 | 87.20% |
| APIS CAPITAL ADVISORS, LLC | 42,500 | $4,234,000 | 4.71% |
| BB BIOTECH AG | 1,384,706 | $137,931,000 | 4.47% |
| Selkirk Management LLC | 64,300 | $6,405,000 | 3.82% |
| HealthCor Management, L.P. | 575,000 | $57,276,000 | 3.19% |
| Opus Point Partners Management, LLC | 31,377 | $3,125,000 | 3.09% |
| SENZAR ASSET MANAGEMENT, LLC | 79,500 | $7,919,000 | 2.32% |
| Eventide Asset Management | 211,100 | $21,028,000 | 2.30% |
| Arlington Capital Management, Inc. | 26,177 | $2,607,000 | 2.21% |
| Orbimed Advisors | 2,268,900 | $226,005,000 | 2.16% |